Sponsor or institution

Clinical trials and research at Chugai Pharmaceutical

• 6Clinical trials
• 22Countries

Newest trials

All recruiting trials (6)

• AQUA07 in ALK-positive NSCLC (phase 1)

  This early-stage trial tests AQUA07 alone and with lorlatinib to see if it is safe and tolerable for adults with ALK-positive non-small cell lung cancer who have tried other ALK inhibitors.

  Recruiting at 7 sites Phase 1 Chugai Pharmaceutical · Houston, Texas and 6 other locations · NCT07617337

• DONQ52 to reduce intestinal damage from gluten in celiac disease

  This study will try DONQ52 in people with celiac disease on a gluten-free diet to see if it reduces small intestinal damage and symptoms after simulated inadvertent gluten exposure.

  Recruiting at 74 sites Phase 2 Chugai Pharmaceutical · Anniston, Alabama and 73 other locations · NCT07239336

• Phase 1 ALPS12 treatment for extensive-stage small cell lung cancer

  This trial tests a new drug called ALPS12, given alone or with obinutuzumab, in adults with extensive-stage small cell lung cancer that has returned after prior therapy.

  Recruiting at 6 sites Phase 1 Chugai Pharmaceutical · Hong Kong and 5 other locations · NCT07107490

• AUBE00 for advanced or metastatic solid tumors with KRAS alterations

  This trial will test AUBE00, alone and with cetuximab, in adults with advanced or metastatic KRAS‑altered solid tumors who have exhausted standard therapies.

  Recruiting at 5 sites Phase 1 Chugai Pharmaceutical · Grand Rapids, Michigan and 4 other locations · NCT07030959

• Testing RAY121 for various immunological diseases

  This study is testing a new drug called RAY121 to see if it can safely help people with different immune system diseases like antiphospholipid syndrome and dermatomyositis.

  Recruiting at 48 sites Phase 1 Chugai Pharmaceutical · Orange, California and 76 other locations · NCT06371417

• Testing ROSE12 alone and with other cancer treatments for solid tumors

  This study is testing a new cancer treatment called ROSE12, both on its own and with other therapies, to see how safe it is and how well it works for people with advanced solid tumors.

  Recruiting at 14 sites Phase 1 Chugai Pharmaceutical · Philadelphia, Pennsylvania and 13 other locations · NCT05907980

Quick answers

How many clinical trials run by Chugai Pharmaceutical are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 22 countries. The most sites are in Japan (5 trials), United States (5 trials), Australia (2 trials), Taiwan (2 trials), Austria (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 5, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →